Hua Medicine (Shanghai) Overview
Get informed when a big investor buys or sells
+ Follow97.73%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, HUMDF shows a ROE of 97.73%. That is above the sector sector average of 11.64%. Scroll down for historical charts and peer comparison views.
The its sector sector average ROE is about 11.64%. Hua Medicine (Shanghai) is at 97.73%, which is higher that average. That is roughly 739.8% above the sector mean. Use the comparison chart on this page to see how HUMDF stacks up against individual peers as well.
Check the historical chart to see whether HUMDF's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Hua Medicine (Shanghai) with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Hua Medicine (Shanghai)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 97.73%) with ownership activity and broader fundamentals.
